SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-24-008747
Filing Date
2024-03-20
Accepted
2024-03-20 20:01:43
Documents
1
Period of Report
2024-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 2041
  Complete submission text file 0001437749-24-008747.txt   3803
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CORCEPT THERAPEUTICS 149 COMMONWEALTH DRIVE MENLO PARK CA 94010
Business Address
Lo Steven (Reporting) CIK: 0001501959 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35285 | Film No.: 24769137